Rare diseases
Investigational molecules
Locations
Back to Germany989 clinical trials in Essen, Germany across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on TIN816 for Preventing Acute Kidney Injury in Adults Undergoing Cardiac Surgery
GermanyStudy of Darovasertib and Crizotinib for Patients with Metastatic Uveal Melanoma Who Are HLA-A2 Negative
GermanyStudy of Ruxolitinib for Patients with High-Risk Polycythemia Vera or High-Risk Essential Thrombocythemia
GermanyStudy on Atezolizumab with Drug Combination for Patients with Gastric Cancer and Esophagogastric Junction Adenocarcinoma
GermanyStudy on Reduced Intensity Radio-Chemotherapy for Stage IIA/B Seminoma Using Etoposide, Cisplatin, and Carboplatin for Patients with Stage IIA/B Seminoma
GermanyStudy of eftilagimod alpha with pembrolizumab combination therapy for patients with metastatic head and neck cancer who have not received previous treatment
GermanyStudy on the Safety and Effectiveness of IMGN151 for Women with Recurrent Endometrial and Ovarian Cancer
GermanyStudy of Nivolumab for Patients with High-Risk Stage II Melanoma After Surgery
GermanyStudy on the Effectiveness and Safety of Mitapivat for Patients with Sickle Cell Disease
GermanyStudy on Atezolizumab for Patients with High-Risk Stage II or Stage III Colorectal Cancer Not Eligible for Oxaliplatin Chemotherapy
GermanyStudy Comparing Divarasib, Sotorasib, and Adagrasib for Patients with Advanced or Metastatic KRAS G12C-Positive Non-Small Cell Lung Cancer
GermanyStudy of Sacituzumab Govitecan compared to standard therapy in HER2-negative breast cancer patients with high risk of relapse after neoadjuvant treatment
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on metastatic colorectal cancer, breast cancer, and lymphoma treatments. Studies evaluate novel therapeutic combinations and targeted approaches for various cancer types.
Research includes evaluation of new drug combinations and immunotherapy approaches.
Studies examining preventive treatments for respiratory syncytial virus and related infections. Research focuses on vaccine development and immune response in different age groups.
Emphasis on protecting vulnerable populations including older adults and at-risk individuals.
Clinical research addressing Alzheimer's disease and acute cerebral ischemic stroke. Investigations into novel therapeutic approaches and diagnostic tools.
Focus on improving patient outcomes through innovative treatment strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
